Don V. Jackson
Impact in
Papers in
- Oncology 46
- Cancer Treatment and Pharmacology 22
- Lung Cancer Research Studies 16
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Charles L. Spurr (51 shared papers)Hyman Bernard Muss (50 shared papers)Frederick Richards (38 shared papers)M. Robert Cooper (37 shared papers)Dougľas R. White (42 shared papers)John J. Stuart (31 shared papers)Richard A. Bender (3 shared papers)Mark Allen O’Rourke (3 shared papers)
- Journals
- Cancer (15 papers)Cancer Chemotherapy and Pharmacology (11 papers)Journal of Clinical Oncology (10 papers)Investigational New Drugs (5 papers)Journal of Neuro-Oncology (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Don V. Jackson
78 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 96
- Oncology 1.3k
- Genetics 220
- Cancer Research 243
- Pulmonary and Respiratory Medicine 495
- Pathology and Forensic Medicine 259
Countries citing papers authored by Don V. Jackson
This map shows the geographic impact of Don V. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don V. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don V. Jackson more than expected).
Fields of papers citing papers by Don V. Jackson
This network shows the impact of papers produced by Don V. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don V. Jackson. The network helps show where Don V. Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Don V. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 302 | |
| 2 | 1977 | 137 | |
| 3 | 1978 | 82 | |
| 4 | Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. | 1979 | 82 |
| 5 | 1988 | 79 | |
| 6 | Pharmacokinetics of vincristine sulfate in adult cancer patients. | 1981 | 78 |
| 7 | 1978 | 68 | |
| 8 | 1984 | 67 | |
| 9 | 1988 | 66 | |
| 10 | 1990 | 66 | |
| 11 | Pharmacokinetics of vincristine in the cerebrospinal fluid of humans. | 1981 | 63 |
| 12 | 1994 | 57 | |
| 13 | 1981 | 52 | |
| 14 | 1981 | 51 | |
| 15 | 1988 | 51 | |
| 16 | 1980 | 48 | |
| 17 | 1986 | 43 | |
| 18 | Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients. | 1989 | 41 |
| 19 | 1984 | 40 | |
| 20 | 1984 | 39 |
About Don V. Jackson
Don V. Jackson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Epidemiology and Genetics, having authored 80 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), Lung Cancer Research Studies (16 papers), Neuroendocrine Tumor Research Advances (15 papers), Lymphoma Diagnosis and Treatment (10 papers), Cancer therapeutics and mechanisms (9 papers), Lung Cancer Treatments and Mutations (8 papers), Breast Cancer Treatment Studies (6 papers) and Chemotherapy-related skin toxicity (5 papers). The work is most often cited by research in Oncology (1.3k citations), Genetics (220 citations), Cancer Research (243 citations), Pulmonary and Respiratory Medicine (495 citations) and Pathology and Forensic Medicine (259 citations). Don V. Jackson has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Charles L. Spurr, Hyman Bernard Muss, Frederick Richards, M. Robert Cooper, Dougľas R. White, John J. Stuart, Richard A. Bender, Mark Allen O’Rourke, V.Sagar Sethi and Paul J. Catalano. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Investigational New Drugs and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.